A Study to Explore the Efficacy of JNJ-89495120 in the Treatment of Major Depressive Disorder

Recruiting

Phase 2

JNJ-89495120A Study to Explore the Efficacy of JNJ-89495120 in the Treatment of Major Depressive Disorder

Sponsor:

Janssen Research & Development, LLC

Code:

NCT06785012

Conditions

Depressive Disorder, Major

Eligibility Criteria

Sex: All

Age: 18 - 64

Healthy Volunteers: Not accepted

Interventions

JNJ-89495120

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-08-20. This information was provided to ClinicalTrials.gov by Janssen Research & Development, LLC on 2025-05-23.